The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Lung Diseases

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lung Diseases


Psychiatry related information on Lung Diseases


High impact information on Lung Diseases


Chemical compound and disease context of Lung Diseases

  • CONCLUSIONS: In preterm infants, early administration of dexamethasone at a moderate dose has no effect on death or chronic lung disease and is associated with gastrointestinal perforation and decreased growth [12].
  • In patients with pulmonary disease, the diffusing capacity for carbon monoxide has been used to predict abnormal gas exchange in the lung [15].
  • In a double-blind trial, 85 patients, 5 to 39 years of age, with mild lung disease (forced expiratory volume in one second [FEV1], > or = 60 percent of the predicted value) were randomly assigned to receive ibuprofen or placebo orally twice daily for four years [16].
  • We reviewed the clinical courses of 171 patients with pulmonary disease due to M. tuberculosis resistant to rifampin and isoniazid who were referred to our hospital between 1973 and 1983 [17].
  • CONCLUSIONS: In preterm infants at risk for lung disease, antenatal administration of thyrotropin-releasing hormone and glucocorticoid is no more beneficial than glucocorticoid alone [18].

Biological context of Lung Diseases


Anatomical context of Lung Diseases


Gene context of Lung Diseases


Analytical, diagnostic and therapeutic context of Lung Diseases


  1. Interleukin-1 receptor antagonist: role in biology. Arend, W.P., Malyak, M., Guthridge, C.J., Gabay, C. Annu. Rev. Immunol. (1998) [Pubmed]
  2. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Rose, M.C., Voynow, J.A. Physiol. Rev. (2006) [Pubmed]
  3. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). Kerem, E., Corey, M., Kerem, B.S., Rommens, J., Markiewicz, D., Levison, H., Tsui, L.C., Durie, P. N. Engl. J. Med. (1990) [Pubmed]
  4. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Davidson, D.J., Dorin, J.R., McLachlan, G., Ranaldi, V., Lamb, D., Doherty, C., Govan, J., Porteous, D.J. Nat. Genet. (1995) [Pubmed]
  5. Low-flow oxygen and bilevel ventilatory support: effects on ventilation during sleep in cystic fibrosis. Milross, M.A., Piper, A.J., Norman, M., Becker, H.F., Willson, G.N., Grunstein, R.R., Sullivan, C.E., Bye, P.T. Am. J. Respir. Crit. Care Med. (2001) [Pubmed]
  6. Qualitative assessment of general movements in high-risk preterm infants with chronic lung disease requiring dexamethasone therapy. Bos, A.F., Martijn, A., van Asperen, R.M., Hadders-Algra, M., Okken, A., Prechtl, H.F. J. Pediatr. (1998) [Pubmed]
  7. Antioxidant properties of melatonin--an emerging mystery. Beyer, C.E., Steketee, J.D., Saphier, D. Biochem. Pharmacol. (1998) [Pubmed]
  8. Lung and brain damage in preterm newborns. Are they related? How? Why? Dammann, O., Leviton, A., Bartels, D.B., Dammann, C.E. Biol. Neonate (2004) [Pubmed]
  9. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Subirà, M., Martino, R., Rovira, M., Vazquez, L., Serrano, D., De La Cámara, R. Ann. Hematol. (2003) [Pubmed]
  10. Immunity to tuberculosis. North, R.J., Jung, Y.J. Annu. Rev. Immunol. (2004) [Pubmed]
  11. Role of CFTR in airway disease. Pilewski, J.M., Frizzell, R.A. Physiol. Rev. (1999) [Pubmed]
  12. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. Stark, A.R., Carlo, W.A., Tyson, J.E., Papile, L.A., Wright, L.L., Shankaran, S., Donovan, E.F., Oh, W., Bauer, C.R., Saha, S., Poole, W.K., Stoll, B.J. N. Engl. J. Med. (2001) [Pubmed]
  13. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. Trembath, R.C., Thomson, J.R., Machado, R.D., Morgan, N.V., Atkinson, C., Winship, I., Simonneau, G., Galie, N., Loyd, J.E., Humbert, M., Nichols, W.C., Morrell, N.W., Berg, J., Manes, A., McGaughran, J., Pauciulo, M., Wheeler, L. N. Engl. J. Med. (2001) [Pubmed]
  14. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. Tyson, J.E., Wright, L.L., Oh, W., Kennedy, K.A., Mele, L., Ehrenkranz, R.A., Stoll, B.J., Lemons, J.A., Stevenson, D.K., Bauer, C.R., Korones, S.B., Fanaroff, A.A. N. Engl. J. Med. (1999) [Pubmed]
  15. Diffusing capacity for carbon monoxide as a predictor of gas exchange during exercise. Sue, D.Y., Oren, A., Hansen, J.E., Wasserman, K. N. Engl. J. Med. (1987) [Pubmed]
  16. Effect of high-dose ibuprofen in patients with cystic fibrosis. Konstan, M.W., Byard, P.J., Hoppel, C.L., Davis, P.B. N. Engl. J. Med. (1995) [Pubmed]
  17. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. Goble, M., Iseman, M.D., Madsen, L.A., Waite, D., Ackerson, L., Horsburgh, C.R. N. Engl. J. Med. (1993) [Pubmed]
  18. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group. Ballard, R.A., Ballard, P.L., Cnaan, A., Pinto-Martin, J., Davis, D.J., Padbury, J.F., Phibbs, R.H., Parer, J.T., Hart, M.C., Mannino, F.L., Sawai, S.K. N. Engl. J. Med. (1998) [Pubmed]
  19. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. Higgins, T.L., Estafanous, F.G., Loop, F.D., Beck, G.J., Blum, J.M., Paranandi, L. JAMA (1992) [Pubmed]
  20. Abnormalities induced by the mutant gene, lpr. Patterns of disease and expression of murine leukemia viruses in SJL/J mice homozygous and heterozygous for lpr. Morse, H.C., Roths, J.B., Davidson, W.F., Langdon, W.Y., Fredrickson, T.N., Hartley, J.W. J. Exp. Med. (1985) [Pubmed]
  21. Lung disease in mice with cystic fibrosis. Kent, G., Iles, R., Bear, C.E., Huan, L.J., Griesenbach, U., McKerlie, C., Frndova, H., Ackerley, C., Gosselin, D., Radzioch, D., O'Brodovich, H., Tsui, L.C., Buchwald, M., Tanswell, A.K. J. Clin. Invest. (1997) [Pubmed]
  22. Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. Xu, Z.Y., Blot, W.J., Xiao, H.P., Wu, A., Feng, Y.P., Stone, B.J., Sun, J., Ershow, A.G., Henderson, B.E., Fraumeni, J.F. J. Natl. Cancer Inst. (1989) [Pubmed]
  23. Expression of the cystic fibrosis gene in adult human lung. Engelhardt, J.F., Zepeda, M., Cohn, J.A., Yankaskas, J.R., Wilson, J.M. J. Clin. Invest. (1994) [Pubmed]
  24. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. Dinh-Xuan, A.T., Higenbottam, T.W., Clelland, C.A., Pepke-Zaba, J., Cremona, G., Butt, A.Y., Large, S.R., Wells, F.C., Wallwork, J. N. Engl. J. Med. (1991) [Pubmed]
  25. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. Eisenbarth, S.C., Piggott, D.A., Huleatt, J.W., Visintin, I., Herrick, C.A., Bottomly, K. J. Exp. Med. (2002) [Pubmed]
  26. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. Folz, R.J., Abushamaa, A.M., Suliman, H.B. J. Clin. Invest. (1999) [Pubmed]
  27. Cystic fibrosis: genotypic and phenotypic variations. Zielenski, J., Tsui, L.C. Annu. Rev. Genet. (1995) [Pubmed]
  28. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. Boring, L., Gosling, J., Chensue, S.W., Kunkel, S.L., Farese, R.V., Broxmeyer, H.E., Charo, I.F. J. Clin. Invest. (1997) [Pubmed]
  29. Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester. Maruyama, M., Hay, J.G., Yoshimura, K., Chu, C.S., Crystal, R.G. J. Clin. Invest. (1994) [Pubmed]
  30. Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice. Bridges, J.P., Wert, S.E., Nogee, L.M., Weaver, T.E. J. Biol. Chem. (2003) [Pubmed]
  31. Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Abraham, D.J., Vancheeswaran, R., Dashwood, M.R., Rajkumar, V.S., Pantelides, P., Xu, S.W., du Bois, R.M., Black, C.M. Am. J. Pathol. (1997) [Pubmed]
  32. Transforming growth factor-beta 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. Finlay, G.A., Thannickal, V.J., Fanburg, B.L., Paulson, K.E. J. Biol. Chem. (2000) [Pubmed]
  33. Role of interferon-gamma in interleukin 12-induced pathology in mice. Car, B.D., Eng, V.M., Schnyder, B., LeHir, M., Shakhov, A.N., Woerly, G., Huang, S., Aguet, M., Anderson, T.D., Ryffel, B. Am. J. Pathol. (1995) [Pubmed]
  34. Heritability of lung disease severity in cystic fibrosis. Vanscoy, L.L., Blackman, S.M., Collaco, J.M., Bowers, A., Lai, T., Naughton, K., Algire, M., McWilliams, R., Beck, S., Hoover-Fong, J., Hamosh, A., Cutler, D., Cutting, G.R. Am. J. Respir. Crit. Care Med. (2007) [Pubmed]
  35. Expression of the Fc-receptor for IgE (Fc epsilon RII, CD23) on alveolar macrophages in extrinsic allergic alveolitis. Pforte, A., Breyer, G., Prinz, J.C., Gais, P., Burger, G., Häussinger, K., Rieber, E.P., Held, E., Ziegler-Heitbrock, H.W. J. Exp. Med. (1990) [Pubmed]
  36. Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. Rennard, S.I., Crystal, R.G. J. Clin. Invest. (1982) [Pubmed]
  37. Gene therapy for lung disease: hype or hope? Albelda, S.M., Wiewrodt, R., Zuckerman, J.B. Ann. Intern. Med. (2000) [Pubmed]
  38. Serum levels of a human lung tumor-associated antigen using an improved radioimmunoassay. Braatz, J.A., Hua, D.T., Princler, G.L. Cancer Res. (1983) [Pubmed]
  39. Interstitial and hemorrhagic pneumonitis induced by mycobacterial trehalose dimycolate. Seggev, J., Goren, M.B., Carr, R.I., Kirkpatrick, C.H. Am. J. Pathol. (1982) [Pubmed]
WikiGenes - Universities